St-Pierre M V, Pang K S
Faculty of Pharmacy, University of Toronto, Canada.
J Pharmacol Exp Ther. 1993 Jun;265(3):1429-36.
In murine liver, temazepam (TZ) and nordiazepam (NZ) are mainly metabolized via N-demethylation and C3-hydroxylation, respectively, to form a common metabolite, oxazepam (OZ), which is then glucuronidated. With these precursors, we tested the hypotheses that the sequential metabolism of a primary metabolite (OZ) is less than that of the preformed metabolite and is dependent on the effective intrinsic clearance (unbound fraction x intrinsic clearance) of its precursor, as predicted by the parallel tube and dispersion models of hepatic drug clearances. Mouse livers were perfused with tracer concentrations of [14C]-NZ, [14C]-TZ and [3H]NZ in a single-pass fashion (2.5 ml/min). The steady-state extraction ratio (E) of [3H]NZ, [14C]NZ and [14C]TZ were 0.29, 0.40 and 0.49, respectively (P < .01), whereas the fractional metabolism (formation rate/total elimination rate of drug) of [3H]-NZ, [14C]NZ and [14C]TZ to form OZ was 0.39, 0.79 and 0.68, respectively. Values of E of [3H]NZ and [14C]NZ and fractional metabolism for OZ formation had differed because of a kinetic isotope effect (around 3.5) that affected the C3-hydroxylation of [3H]NZ. The extraction ratios of OZ (E[OZ,P]) arising from [14C]-NZ and [14C]TZ were both 0.056, and were less than that for preformed OZ (E[OZ]), previously found to be 0.125. The parameter E[OZ,P] was poorly correlated with the extraction ratio of the precursor, was overestimated by the parallel tube and dispersion models, but was highly correlated with the effective intrinsic clearance of the precursor (unbound fraction x intrinsic clearance).(ABSTRACT TRUNCATED AT 250 WORDS)
在小鼠肝脏中,替马西泮(TZ)和去甲西泮(NZ)主要分别通过N-去甲基化和C3-羟基化代谢,形成一种共同代谢产物奥沙西泮(OZ),然后奥沙西泮会进行葡萄糖醛酸化。利用这些前体,我们检验了以下假设:正如肝脏药物清除的平行管模型和弥散模型所预测的那样,初级代谢产物(OZ)的顺序代谢低于预先形成的代谢产物,并且取决于其前体的有效内在清除率(非结合分数×内在清除率)。以单次通过的方式(2.5毫升/分钟)用示踪浓度的[14C]-NZ、[14C]-TZ和[3H]NZ灌注小鼠肝脏。[3H]NZ、[14C]NZ和[14C]TZ的稳态提取率(E)分别为0.29、0.40和0.49(P <.01),而[3H]-NZ、[14C]NZ和[14C]TZ形成OZ的分数代谢(药物形成率/总消除率)分别为0.39、0.79和0.68。由于影响[3H]NZ C3-羟基化的动力学同位素效应(约为3.5),[3H]NZ和[14C]NZ的E值以及OZ形成的分数代谢有所不同。由[14C]-NZ和[14C]TZ产生的OZ的提取率(E[OZ,P])均为0.056,低于先前发现的预先形成的OZ的提取率(E[OZ]),后者为0.125。参数E[OZ,P]与前体的提取率相关性较差,平行管模型和弥散模型对其估计过高,但与前体的有效内在清除率(非结合分数×内在清除率)高度相关。(摘要截短于250字)